Autres langues Verona Pharma plc

Actions

VRNA

US9250501064

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 12/06/2024			Varia. 5j.	Varia. 1 janv.
14,75 ^USD	+10,32 %		+21,90 %	-25,80 %

12/06	Les actions européennes négociées aux États-Unis sous forme de certificats américains d'actions étrangères (ADR) sont en forte hausse mercredi matin.	MT
11/06	Les actions européennes négociées aux États-Unis et les American Depositary Receipts sont en forte baisse mardi.	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

European Equities Traded in the US as American Depositary Receipts Rise Sharply in Wednesday Trading	12/06
European Equities Traded in the US as American Depositary Receipts Trend Sharply Lower in Tuesday Trading	11/06
Tech Firms Lead European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading	06/06
European Equities Traded in the US as American Depositary Receipts Fall in Monday Trading	03/06
European Equities Traded in US as American Depositary Receipts Rise Friday, Poised to End Week Lower	31/05
European Equities Traded in the US as American Depositary Receipts Open Week Lower in Tuesday Trading	28/05
Tech Stocks Lead European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading	23/05
European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading	22/05
European Equities Traded in the US as American Depositary Receipts Start Week Marginally Higher in Monday Trading	20/05
Verona Pharma : VRNA Presentation May 2024	13/05
Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS	10/05
Verona Pharma Signs Financing Agreements for Up to $650 Million	09/05
Verona Pharma Shares Decline After Q1 Loss Widens	09/05
Verona Pharma plc Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update	09/05
Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS	09/05
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading	06/05
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Set to Close Week Lower	03/05
Verona Pharma to Present Additional Analyses of Positive Phase 3 ENHANCE Studies in COPD at ATS 2024	02/05
Verona Pharma to Present Additional Analyses of Positive Phase 3 ENHANCE Studies in COPD at ATS 2024	02/05

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Verona Pharma plc

Actions

VRNA

US9250501064

Autres langues

Filtres